Streetbeat News

Partnerships

AMST

Amesite Inc. has entered into a five-year partnership with Joliet Junior College to provide an advanced learning platform. This collaboration aims to enhance educational experiences through Amesite's innovative technology solutions.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:14 pm

AMD

AMD CEO Lisa Su highlighted AI as the 'most important' technology of the last 50 years, emphasizing its potential for growth and AMD's efforts to capture market share through cloud and edge computing partnerships and AI-powered PCs. Su anticipates 'tremendous growth' in AI over the next three to five years, aiming to make AI accessible to everyone through a range of products.

Portfolio Pulse from Adam Eckert

March 11, 2024 | 9:13 pm

GSM

Ferroglobe and Coreshell have signed a Memorandum of Understanding (MoU) to produce the first battery-grade metallurgical silicon for electric vehicles (EVs), aiming for low-cost, high-range EV batteries in line with the U.S. Inflation Reduction Act.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:12 pm

DVA

The American Diabetes Association (ADA) and DaVita (NYSE:DVA) have expanded their multi-year collaboration to advance chronic disease prevention, focusing on diabetes and chronic kidney disease (CKD). This expansion, announced during National Kidney Month, includes a $1.5 million contribution from DaVita to the ADA's initiatives. The partnership aims to increase awareness, education, and support, especially in communities of color disproportionately affected by these conditions. Efforts include creating educational materials, a dietitian program, and sponsoring ADA's State of Diabetes events.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:44 pm

NEXT

NextDecade Corporation (NASDAQ:NEXT) provided a Q4 2023 business update, focusing on the construction of Phase 1 at the Rio Grande LNG Facility and the expansion capacity to meet global LNG demand. The company is working with Bechtel on construction and has begun FEED and EPC contract processes for Train 4, aiming for a positive FID in H2 2024. Financially, NextDecade has secured loans and issued senior secured notes to support Phase 1 construction, with significant progress reported in project completion percentages for Trains 1, 2, and 3.

Portfolio Pulse from Happy Mohamed

March 11, 2024 | 8:36 pm

AAP

Advance Auto Parts has appointed three new independent directors and entered into a cooperation agreement with Third Point and Saddle Point Management. This strategic move aims to enhance governance and drive shareholder value.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:20 pm

NPWR

NET Power Inc. (NYSE:NPWR) reported its Q4 and year-end 2023 results, highlighting significant progress in its projects and strategic partnerships. The company ended 2023 with approximately $637M in cash and short-term investments, with no debt. Key developments include advancing the Project Permian in West Texas, signing agreements with Baker Hughes and Lummus Technology, and planning for equipment validation campaigns. NET Power also completed a business combination with Rice Acquisition Corp. II, becoming publicly listed on the NYSE in June 2023.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:11 pm

ALTO

Alto Ingredients has announced its intention to collaborate with Vault on a carbon capture and storage initiative. As part of this initiative, Alto will install equipment to capture carbon dioxide generated from its production process at its Pekin campus. Vault will then be responsible for the transportation and storage of these emissions.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:04 pm

AAP

Advance Auto Parts (AAP) shares are experiencing an uptick after reports emerged that the company is nearing a settlement with Third Point, which includes the addition of three new board members.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 7:57 pm

ASLN

Piper Sandler released a note on ASLAN Pharmaceuticals, indicating the company's belief in the value and differentiation of its once-monthly subcutaneous Eblasakimab compared to Dupixent, which is administered every other week. This suggests ASLAN Pharmaceuticals is open to partnerships or acquisition based on the unique positioning of Eblasakimab.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 6:45 pm